Bluejay Diagnostics, Inc. Increase (Decrease) in Inventories
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Inventories of $671.25 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2023-08-14
- Bluejay Diagnostics, Inc. increase (decrease) in inventories for the quarter ending 2022-06-30 was -$221.92K.
- Bluejay Diagnostics, Inc. increase (decrease) in inventories for the quarter ending 2022-03-31 was $893.17K.
- Bluejay Diagnostics, Inc. increase (decrease) in inventories for the quarter ending 2021-12-31 was $0.00.
- Bluejay Diagnostics, Inc. increase (decrease) in inventories for the quarter ending 2021-09-30 was $0.00.
- Bluejay Diagnostics, Inc. increase (decrease) in inventories for fiscal 2021 was -$84.76K.
- Bluejay Diagnostics, Inc. increase (decrease) in inventories for fiscal 2020 was -$38.75K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$221.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $671.25K 10-Q · filed 2023-08-14 | $671.25K derived: sum of 3 quarters · filed 2023-08-14 | $671.25K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $893.17K 10-Q · filed 2023-05-11 | $893.17K derived: sum of 2 quarters · filed 2023-05-11 | $893.17K derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $0.00 derived: sum of 2 quarters · filed 2023-03-20 | -$84.76K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-12-16 | -$84.76K 10-Q · filed 2021-12-16 | ||
| 2021-06-30 | -$84.76K 10-Q · filed 2022-08-10 | |||
| 2020-12-31 | -$123.51K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$38.75K 10-K · filed 2022-03-10 | ||
| 2020-09-30 | $84.76K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |